Clinical Trial Update: Arbaclofen in Children and Adolescents With ASD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for arbaclofen in children and adolescents with Autism Spectrum Disorder has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Arbaclofen (arbaclofen)

Snippet

Sponsor: Celso Arango, MD, PhD | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED